Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): M. Malla, A. Esmail, A. Tin, M.M. Khayat, L. Bathla, C. Bridges, C.M. Brewer, J. Ferguson, J.B. Ortiz, J. Ensor, K. Magee, J. Yu, A.R. He, T. Cannon, A. Winer, G.G. King, A. Mahipal, A. Nagarajan, J.W. Franses, A. Fungtammasan
Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826000440?dgcid=rss_sd_all
Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826000440?dgcid=rss_sd_all
“Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.” ESMO Gastrointestinal Oncology.
@article{article44833,
title = {Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826000440?dgcid=rss_sd_all}
}